Evaluation of opioid prescription patterns among patients undergoing thyroid surgery
Abstract Background There is variability in opioid prescription patterns among surgeons performing thyroidectomy. Thus, the aim of this study is to evaluate opioid prescription rates and opioid use among hemithyroidectomy (HT) and total thyroidectomy (TT) patients. Design/Method An electronic postoperative survey was distributed to assess opiate use among patients undergoing HT/TT. Groups were compared using t‐ tests, chi‐square tests, and analysis of variance. Results A total of 142 opiate naïve patients were included, of which 75 (52.8%) underwent HT and 67 (47.1%) underwent TT. The mean number of tablets prescribed was 21.3 (HT = 22.1, TT = 20.4; P= 0.3), with a mean of 14.1 tablets unused after surgery (HT = 13.2 tablets, TT = 15.0 tablets; P= 0.44). The mean morphine milligram equivalent (MME) prescribed was 150.1 mg (HT = 159.0 mg, TT = 140.2 mg; P= 0.3), with a mean of 98.2 MME unused after surgery (HT = 93.7 mg, TT = 103.2 mg; P= 0.6). Conclusions Opioids are overprescribed after thyroid surgery. Avoidance of overprescribing is vital in mitigating the current opioid crisis..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Head & Neck - 43(2021), 3, Seite 903-908 |
| Beteiligte Personen: |
McCrary, Hilary C. [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2021 Wiley Periodicals LLC. |
|---|
| Umfang: |
6 |
|---|
| doi: |
10.1002/hed.26551 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY00699721X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY00699721X | ||
| 003 | DE-627 | ||
| 005 | 20230307164534.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/hed.26551 |2 doi | |
| 028 | 5 | 2 | |a HED_HED26551.xml |
| 035 | |a (DE-627)WLY00699721X | ||
| 035 | |a (WILEY)HED26551 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.83 |2 bkl | ||
| 084 | |a 44.94 |2 bkl | ||
| 100 | 1 | |a McCrary, Hilary C. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluation of opioid prescription patterns among patients undergoing thyroid surgery |
| 264 | 1 | |c 2021 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 Wiley Periodicals LLC. | ||
| 520 | |a Abstract Background There is variability in opioid prescription patterns among surgeons performing thyroidectomy. Thus, the aim of this study is to evaluate opioid prescription rates and opioid use among hemithyroidectomy (HT) and total thyroidectomy (TT) patients. Design/Method An electronic postoperative survey was distributed to assess opiate use among patients undergoing HT/TT. Groups were compared using t‐ tests, chi‐square tests, and analysis of variance. Results A total of 142 opiate naïve patients were included, of which 75 (52.8%) underwent HT and 67 (47.1%) underwent TT. The mean number of tablets prescribed was 21.3 (HT = 22.1, TT = 20.4; P= 0.3), with a mean of 14.1 tablets unused after surgery (HT = 13.2 tablets, TT = 15.0 tablets; P= 0.44). The mean morphine milligram equivalent (MME) prescribed was 150.1 mg (HT = 159.0 mg, TT = 140.2 mg; P= 0.3), with a mean of 98.2 MME unused after surgery (HT = 93.7 mg, TT = 103.2 mg; P= 0.6). Conclusions Opioids are overprescribed after thyroid surgery. Avoidance of overprescribing is vital in mitigating the current opioid crisis. | ||
| 700 | 1 | |a Newberry, Christopher I. |4 aut | |
| 700 | 1 | |a Casazza, Geoffrey C. |4 aut | |
| 700 | 1 | |a Cannon, Richard B. |4 aut | |
| 700 | 1 | |a Ramirez, Alexander L. |4 aut | |
| 700 | 1 | |a Meier, Jeremy D. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Head & Neck |g 43(2021), 3, Seite 903-908 |w (DE-627)WLY006984223 |x 10970347 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2021 |g number:3 |g pages:903-908 |g extent:6 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 44.83 |q ASE |
| 936 | b | k | |a 44.94 |q ASE |
| 951 | |a AR | ||
| 952 | |d 43 |j 2021 |e 3 |h 903-908 |g 6 | ||